Ground was broken in April 2017 on the first commercial scale FeedKind® protein manufacturing plant in Memphis, Tennessee through NouriTech™, a venture formed in 2016 with investments from Cargill, Calysta and several third party investors. The NouriTech facility will be home to the world’s largest gas fermentation operation, and will produce the FeedKind protein family of safe, sustainable nutritional ingredients for fish, livestock and pets. The plant is expected to come online in 2019. Cargill and Calysta announced plans for this facility in November 2016. Cargill initially invested in Calysta through the company’s Series C investment round in February 2016.
Calysta and NatureWorks (www.natureworksllc.com) have an R&D collaboration to transform methane into the lactic acid building block for bioplastics. It was announced on June 18, 2013. The companies have an exclusive, multi-year collaboration to research and develop a practical, world-scale production process for fermenting methane ̶ a potent greenhouse gas (GHG) ̶ into lactic acid, the building block for NatureWorks’ Ingeo™, lactide intermediates and polymers made from renewable materials. If the collaboration results in the successful commercialization of this first-of-its-kind technology, the cost to produce Ingeo would be structurally lowered, and the wide range of Ingeo based consumer and industrial products could be produced from an even broader set of carbon-based feedstocks, complementary to what is already in use by NatureWorks. Read more.